Queensland researchers have solved the century-old mystery of why patients who suffer severe spinal cord and brain injuries ...
EG 427 SAS has received IND clearance from the FDA for EG-110A, a gene therapy for the treatment of neurogenic detrusor overactivity in patients with spinal cord injury. A phase Ib/IIa study is being ...
Hosted on MSN
Clinical trial tests herpes virus-based therapy for neurogenic bladder in people with spinal cord injury
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback